Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orally available Src tyrosine kinase inhibitor characterized in vitro and in vivo

July 15, 2003

Roche presents new series of antitumor agents targeting CDK2

July 15, 2003

Selective small-molecule inhibitors of CDK4 identified at Roche

July 15, 2003

AVP-893: a prototype of a novel class of antitumor agents designed at Avanir

July 15, 2003

Novel methionine aminopeptidase type 2 inhibitors discovered by GSK scientists

July 15, 2003

Optimization of CDK-2 inhibitor series as orally active antitumor agents

July 14, 2003

BMS presents second-generation farnesyltransferase inhibitors at AACR meeting

July 14, 2003

Ivax initiates phase II trial of talampanel for brain cancer

July 14, 2003

Enrollment completed for phase I/II study of 131I-TM-601 in glioma

July 14, 2003

Promising activity reported for Nipent combination therapy in NHL

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...